← Eichor
Study identifier: NCT07324941 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants

Condition: Apnea Neonatal · Apnea of Prematurity  ·  Sponsor: Uludag University

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to 1 Month
Healthy volunteersNo

About this study

The aim of this observational study is to investigate whether functional maturation assessment by electroencephalography in preterm infants can provide reliable data for the safe discontinuation of caffeine therapy without recurrence of apnea. In preterm infants receiving caffeine therapy, an assessment of maturation will be performed by EEG at the time when discontinuation of caffeine treatment is planned.

This description comes directly from the study's public registry record.

Talk to the study team

Salih Çağrı Çakır  ·  +90 533 3453739  ·  salihcagri@uludag.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Neonatology, Department of Pediatrics, Bursa Uludağ University Faculty of MedicineBursa, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07324941